Document Classification

Section Type: RESULTS

Text: Patients randomized to a starting dose of 40 mg/day CBZ had lower total (98 + / - 10 vs 158 + / - 11 nmol/l, P < 0. 001) and free T4 (19. 4 + / - 2. 6 vs 35. 2 + / - 3. 7 pmol/l, P < 0. 001) and total (2. 6 + / - 0. 3 vs 4. 3 + / - 0. 4 nmol/l, P < 0. 001) and free T3 (8. 3 + / - 1. 0 vs 13. 7 + / - 1. 2 pmol/l, P < 0. 01) at 4 weeks than those receiving 20 mg/day.